ClinicalTrials.Veeva

Menu

Continuous Glucose Monitoring During Diets That Differ in Glycemic Load (GLOW)

Unilever logo

Unilever

Status

Completed

Conditions

Glucose Metabolism Disorders

Treatments

Dietary Supplement: High glycemic load
Dietary Supplement: Low glycemic load

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02926118
REF-CSC-2682

Details and patient eligibility

About

This study test whether a Continuous Glucose Monitor can pickup differences in glucose (in the interstitial fluid) during a dietary intervention using meals with either a high with a low glycemic load.

Full description

The aim of this study is to determine the suitability of a continuous glucose monitor to detect the impact of a dietary intervention on postprandial blood glucose levels in normal, healthy, free living subjects. We will compare a dietary intervention of meals with a high glycemic load (high post-meal blood glucose) versus meals with a low glycemic load (low post-meal blood glucose) in a cross-over study. In addition, the glucose profiles obtained both via venous blood sampling and via continuous glucose monitor following a standard carbohydrate load will be compared.

Enrollment

23 patients

Sex

All

Ages

50 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Apparently healthy males and post-menopausal females
  • Age at start of the study ≥ 50 and ≤ 70 years
  • Body mass index (BMI) ≥ 25.0 and ≤ 35.0 kg/m2
  • Fasting blood glucose value of subjects is ≥ 3.4 and < 6.1 mmol/L at screening
  • Being used to eat three meals a day
  • Having a general practitioner
  • Agreeing to be informed about medically relevant personal test-results by a physician
  • Accessible veins on arms as determined by examination at screening.

Exclusion criteria

  • Having a medical conditions which might affect the study measurements (including but not limited to: diabetes type 1 and type 2, gastrointestinal disorders, gastrointestinal surgery and inflammatory diseases, as judged by the study physician
  • Reported use of over-the-counter or prescribed medication or food supplements, which may interfere with study measurements as judged by the principal investigator
  • Use of oral antibiotics in 40 days or less prior to the start of the study
  • Reported participation in another nutritional or biomedical study 3 months before the screening or during the study
  • Reported participation in night shift work 2 weeks prior to screening or during the study. Night work is defined as working between mid-night and 6.00 am
  • Reported intense sporting activities > 2h/w. Intense sporting activities are defined as those activities that cause a lack of breath which limits the ability to have a normal conversation
  • Reported alcohol consumption > 10 units/week (female) or > 14 units/week (male)
  • Reported use of any nicotine containing products in the 6 months preceding the study and willing to abstain from use of nicotine containing products during the study itself
  • Reported dietary habits: medically prescribed diet, slimming diet, vegetarian
  • Reported weight loss/gain (> 3 kg) in the last 2 months before the study
  • Being an employee of Unilever or research departments in NUTRIM or the Maastricht University Medical Centre (MUMC+) collaborating in this study
  • Known allergy or intolerance to food products.
  • Blood donation in the past 3 months

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

23 participants in 2 patient groups

Low glycemic load
Experimental group
Description:
Low glycemic load
Treatment:
Dietary Supplement: Low glycemic load
High glycemic load
Experimental group
Description:
High glycemic load
Treatment:
Dietary Supplement: High glycemic load

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems